欢迎来到上海通蔚!

021-54845833/15800441009

品质保证 · 通蔚试剂

当前位置: 首页 > 科研产品 > 科研抗体 > 一抗 > 兔抗AKT1/AKT2/AKT3 (phospho-Tyr315/316/312)多克隆抗体

产品中心

  • 兔抗AKT1/AKT2/AKT3 (phospho-Tyr315/316/312)多克隆抗体

    规格:
    数量:

    购买数量

    价格:
    • 品牌 : 通蔚生物
    • 目录号 : TW1635
    • 应用 : 仅用于科研使用
    • 保存条件 : 低温保存
    • 货期 : 现货
    • 商品库存:35
  • 商品详情
  • 参考文献
  • 说明书下载
  • 商品评论0
  • 相关产品

中文名称:兔抗AKT1/AKT2/AKT3 (phospho-Tyr315/316/312)多克隆抗体

英文名称: Anti-AKT1/AKT2/AKT3 (phospho-Tyr315/316/312) rabbit polyclonal antibody

相关类别: 一抗

储      存: 冷冻(-20℃) 避光

宿      主: Rabbit

抗      原: AKT1/AKT2/AKT3 (phospho-Tyr315/316/312)

反应种属: Human, Mouse, Rat

标 记 物: Unconjugate

克隆类型: rabbit polyclonal

技术规格

Background:

General protein kinase capable of phosphorylating several known proteins. Phosphorylates TBC1D4. Signals downstream of phosphatidylinositol 3-kinase (PI3K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor I (IGF-I). Plays a role in glucose transport by mediating insulin-induced translocation of the GLUT4 glucose transporter to the cell surface. Mediates the antiapoptotic effects of IGF-I. Mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1. Promotes glycogen synthesis by mediating the insulin-induced activation of glycogen synthase. /General protein kinase capable of phosphorylating several known proteins. IGF-1 leads to the activation of AKT3, which may play a role in regulating cell survival. Capable of phosphorylating several known proteins. Truncated isoform 2/PKB gamma 1 without the second serine phosphorylation site could still be stimulated but to a lesser extent.

Applications:

WB, IHC, IF

Name of antibody:

AKT1/AKT2/AKT3 (phospho-Tyr315/316/312)

Immunogen:

Synthetic peptide of human AKT1/AKT2/AKT3 (phospho-Tyr315/316/312)

Full name:

AKT1/AKT2/AKT3 (phospho-Tyr315/316/312)

SwissProt:

P31749

IHC positive control:

Human breast carcinoma

IHC Recommend dilution:

50-100

WB Predicted band size:

60 kDa

WB Positive control:

HepG2 cells treated with EGF

WB Recommended dilution:

500-1000

IF Positive control:

Hela cells

IF Recommended dilution

100-200